Dry eye disease is more than tear deficiency. Dr Christopher Rapuano reviews its burden, key diagnostic mimics, practical evaluation, and individualized treatment options for ocular surface disease. Medscape
Tag: Commentary
Dry Eye Disease: 5 Things to Know
Dry eye disease requires targeted, phenotype-directed care beyond basic artificial tears. Discover five key clinical insights on meibomian gland dysfunction and novel water-free therapies. Medscape Ophthalmology
Personalized Care Is the Future of Dry Eye Management
New insights into dry eye disease are advancing personalized care, using underlying causes, targeted diagnostics and treatment to improve outcomes and quality of life. Medscape
A1c: Not as Useful in Practice as One Might Think
Ms Said and Dr Paauw explain several drawbacks of use of A1c in practice. Medscape Internal Medicine
Trust Is Earned, Not Assumed
Trust flows both ways between physicians and their patients, says John Whyte, MD, MPH, CEO and executive vice president of the American Medical Association. Dr Whyte shares how he seeks to build that trust. Medscape
How to Mange Benign Prostatic Hypertrophy in Primary Care
Dr Neil Skolnik breaks down the American Urological Association guideline for the management of benign prostatic hypertrophy. Medscape Family Medicine
How to Manage Benign Prostatic Hypertrophy in Primary Care
Dr Neil Skolnik breaks down the American Urological Association guideline for the management of benign prostatic hypertrophy. Medscape Family Medicine
The Expanding Use of CGM for Diabetes
Dr Anne Peters discusses the expanding use of continuous glucose monitoring in people with diabetes. Medscape Diabetes & Endocrinology
Are GLP-1 Receptor Agonists Safe for the Eyes?
Do their associations with nonarteritic anterior ischemic optic neuropathy and other adverse outcomes make these drugs more risky than beneficial? Medscape Global
New Guidelines for Managing Metastatic Uveal Melanoma
Dr Teresa Amaral reviews new uveal melanoma guidelines, detailing how to stratify liver-directed therapies and systemic immunotherapy based on HLA status. Medscape Oncology
Managing Localized Uveal Melanoma: New Guideline Review
Dr Teresa Amaral reviews new guidelines for localized uveal melanoma, covering enucleation, radiotherapy nuances, and the current evidence on adjuvant systemic treatment. Medscape Oncology
Imaging and Staging Essentials in Uveal Melanoma
Dr Teresa Amaral reviews new uveal melanoma guidelines, focusing on AJCC 8th Edition staging, the Liverpool prognostic tool, and the essential role of BAP1 and PRAME expression. Medscape Oncology
ESMO Update: New Guidance for Rare Uveal Melanoma
Dr Teresa Amaral breaks down the essential new guidelines for uveal melanoma. Stay ahead of the latest standards in patient care. Medscape Oncology
The Pitt Season 2: EM Docs Tackle Tough Diagnoses (Part 3)
Drs Robert Glatter and Amy Faith Ho continue their review of The Pitt season 2, tackling retinal artery occlusion, phytophotodermatitis, and ovarian torsion. They unpack clinical accuracy, informed consent, and bias in emergency care. Medscape Emerg…
GLP-1 Drugs Under Scrutiny: How Real Are the Risks?
Gastrointestinal adverse effects remain a key barrier to continued use of these agents, with slower dose titration emerging as a strategy to improve tolerability and adherence. Medscape News Europe
Myth of the Month: GLP-1s Have Many Dangerous Side Effects
Dr Paauw debunks concerns about thyroid cancer, suicide, and pancreatitis. Medscape Internal Medicine
Physicians Must Lead AI Integration in Medicine
It’s no longer a question that AI will shape the future of medicine. But it must be accountable and transparent, and physicians must lead its integration into clinical practice, writes AMA’s CEO, John Whyte, MD, MPH. Medscape Internal Medicine
Outpatient Management of Otitis Media in Young Children
Dr Nina Lum discusses the management of acute otitis media in young children in the outpatient setting. Medscape
PRAME TCR Therapy Delivers Breakthrough in Uveal Melanoma
Dr Teresa Amaral reviews ESMO 2025 data showing unprecedented response rates with PRAME-directed TCR therapy in metastatic uveal melanoma. Medscape Oncology
ESMO 2025: CheckMate 238 Update Reinforces Nivolumab Benefit
Dr Teresa Amaral discusses the 9-year update on CheckMate 238 presented at ESMO 2025. Medscape Oncology